Abdelrahim M - Search Results

1

Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.

Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, Kamat AM. Kassouf W, et al. Among authors: abdelrahim m. Cancer Res. 2006 Jan 1;66(1):412-8. doi: 10.1158/0008-5472.CAN-05-2755. Cancer Res. 2006. PMID: 16397256

2

Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells.

Abdelrahim M, Samudio I, Smith R 3rd, Burghardt R, Safe S. Abdelrahim M, et al. J Biol Chem. 2002 Aug 9;277(32):28815-22. doi: 10.1074/jbc.M203828200. Epub 2002 Jun 6. J Biol Chem. 2002. PMID: 12052832 Free article.

3

The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.

Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S. Wormke M, et al. Among authors: abdelrahim m. Mol Cell Biol. 2003 Mar;23(6):1843-55. doi: 10.1128/MCB.23.6.1843-1855.2003. Mol Cell Biol. 2003. PMID: 12612060 Free PMC article.

4

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.

Khan S, Abdelrahim M, Samudio I, Safe S. Khan S, et al. Among authors: abdelrahim m. Endocrinology. 2003 Jun;144(6):2325-35. doi: 10.1210/en.2002-0149. Endocrinology. 2003. PMID: 12746293

5

Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

Abdelrahim M, Smith R 3rd, Safe S. Abdelrahim M, et al. Mol Pharmacol. 2003 Jun;63(6):1373-81. doi: 10.1124/mol.63.6.1373. Mol Pharmacol. 2003. PMID: 12761348

6

Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.

Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S. Stoner M, et al. Among authors: abdelrahim m. Oncogene. 2004 Feb 5;23(5):1052-63. doi: 10.1038/sj.onc.1207201. Oncogene. 2004. PMID: 14647449

7

A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.

Qin C, Morrow D, Stewart J, Spencer K, Porter W, Smith R 3rd, Phillips T, Abdelrahim M, Samudio I, Safe S. Qin C, et al. Among authors: abdelrahim m. Mol Cancer Ther. 2004 Mar;3(3):247-60. Mol Cancer Ther. 2004. PMID: 15026545

8

Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha.

Pearce ST, Liu H, Radhakrishnan I, Abdelrahim M, Safe S, Jordan VC. Pearce ST, et al. Among authors: abdelrahim m. Cancer Res. 2004 Apr 15;64(8):2889-97. doi: 10.1158/0008-5472.can-03-1770. Cancer Res. 2004. PMID: 15087408

9

Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.

Hong J, Samudio I, Liu S, Abdelrahim M, Safe S. Hong J, et al. Among authors: abdelrahim m. Endocrinology. 2004 Dec;145(12):5774-85. doi: 10.1210/en.2004-0686. Epub 2004 Sep 2. Endocrinology. 2004. PMID: 15345676

10

Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.

Abdelrahim M, Smith R 3rd, Burghardt R, Safe S. Abdelrahim M, et al. Cancer Res. 2004 Sep 15;64(18):6740-9. doi: 10.1158/0008-5472.CAN-04-0713. Cancer Res. 2004. PMID: 15374992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters